Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Serum interleukin-6 receptor in polymyalgia rheumatica: a potential marker of relapse/recurrence risk.

Authors
Type
Published Article
Journal
Arthritis and rheumatism
Publication Date
Volume
59
Issue
8
Pages
1147–1154
Identifiers
DOI: 10.1002/art.23924
PMID: 18668607
Source
Medline
License
Unknown

Abstract

Our data support the identification of a potential prognostic marker of PMR outcome that might have important implications in clinical practice. Because targeting sIL-6R with blocking antibodies has proven useful in other rheumatic disorders, our results could suggest the opportunity to evaluate sIL-6R-blocking treatment in patients with PMR and elevated levels of sIL-6R at disease onset.

Statistics

Seen <100 times